findmyKOL
Clinical trialNCT05106101CompletedPhase 1Interventional

L-glutamine Treatment in Patients With Diverticulosis

SponsorEmmaus Medical, Inc.Enrollment9Diverticulosis, Colonic
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the study is evaluate the safety and efficacy of L-glutamine as a treatment for patients with diverticulosis.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the Lundquist Institute at Harbor-Ucla Medical Center

    Torrance, California, United States

  • Ventura Clinical Trials

    Ventura, California, United States

  • Clinical Trials of Texas, Inc.

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Glutamine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Jul 2019
Primary completion
30 Dec 2022
Completion
30 Dec 2022
Last update posted
16 Feb 2023
Registered enrollment
9
Registry id
NCT05106101
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.